Month: January 2023
-
Vitamin D Improves Symptoms of Toxic Erythema of Chemotherapy
High doses of vitamin D alleviated symptoms for patients with toxic erythema of chemotherapy significantly faster than current treatments, according to a recent study.
-
Wireless Brain Implant Monitors Neurotransmitters in Real Time
Scientists have developed a wireless, battery-free implant capable of monitoring dopamine signals in the brain in real-time, an advance that could aid in understanding the role neurochemicals play in neurological disorders.
-
Mature ‘Lab Grown’ Neurons Hold Promise for Neurodegenerative Disease
Northwestern scientists have created the first highly mature neurons from human induced pluripotent stem cells, a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases.
-
Improving Treatment for Hairy Cell Leukemia
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
-
Novel Cell ‘Switches’ Promote Lung Cancer Growth, Treatment Resistance
Northwestern Medicine investigators have revealed new insights into how cell type switches facilitate tumor growth and treatment resistance in small cell lung cancer, according to findings published in Science Advances.
-
Identifying New Genetic Variants Linked to Heart Failure
Scientists have identified new genes linked to heart failure, according to a study published in Nature Communications.
-
Direct-to-Consumer Online Platforms Expand Access, but Often Fail to Convey Risks of Testosterone Therapy
Direct-to-consumer platforms for testosterone therapy don’t always provide care in concordance with professional guidelines, according to a recent Northwestern Medicine study.
-
Exploring Genetic Regulation of Immunoglobulin A
Increased levels of the antibody immunoglobulin A (IgA) are correlated with the manifestation of several diseases and African ancestry, according to findings published in Nature Communications.
-
Investigating Quality of Life in Large B-cell Lymphoma
Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.
